Monday, July 23, 2018
Company News: Page (1) of 1 - 07/11/18 Email this story to a friend. email article Print this page (Article printing at page facebook
It's Never 2 Late Announces Lisa Taylor as New CEO
Former healthcare executive at West Corporation and TeleVox Software co-founder joins iN2L to drive continued growth in senior living market
(July 11, 2018)

DENVER, July 11, 2018 /PRNewswire/ -- It's Never 2 Late® (iN2L), the leading provider of person-centered digital engagement to the senior living market, announced the appointment of Lisa Taylor as its new Chief Executive Officer effective July 9, 2018.

Lisa Taylor has been appointed as iN2L's new Chief Executive Officer.

"We are extremely excited to have Lisa Taylor join iN2L as our new CEO. Lisa brings a track record of successfully building and leading innovative organizations that are pioneers in their category," said Jack York, co-founder and President of iN2L. "Lisa's experience, leadership ability, and cultural fit with our team and market make her the ideal leader for iN2L's next stages of growth. We look forward to working with her to extend our impact and leadership across the senior living market, improving older adults' quality of life, enabling communities to differentiate themselves in the marketplace, and delivering value to the multiple constituencies that are touched by our technology.

Taylor joins iN2L after recently serving as CEO of West Corporation's healthcare division, which includes TeleVox Software. As a co-founder of TeleVox, Taylor led its growth from inception to a market leader in patient engagement technology. Under Taylor's leadership, West grew to facilitate more than 1.5 million daily healthcare interactions through TeleVox, on behalf of 140,000 providers. 

"I am incredibly impressed with iN2L's trailblazing leadership in the person-centered digital engagement space," said Taylor. "Jack and his team have done an amazing job listening to the needs of the market and developing technology that truly impacts older adults' lives. Beyond its ability to significantly enhance quality of life and family interactions, iN2L is a differentiating technology solution for the communities that adopt it. As the vast aging population continues to grow, there is great opportunity to expand our reach and help older adults stay connected, engaged, and energized. iN2L is uniquely positioned to bridge older adults' communication and interactions with their families, caregivers, and the world. I see tremendous opportunity at iN2L and I am excited by what we will achieve together."

About It's Never 2 Late
It's Never 2 Late® (iN2L) is the leading provider of person-centered digital engagement technology to the senior living market, with over 2,300 communities in the United States and Canada. Founded in 1999, the company's picture-based, touchscreen interface provides easy access to unparalleled content, regardless of users' physical and cognitive abilities. iN2L's media library offers over 4,000 social, educational, spiritual and gaming content options. For more information, visit


It’s Never 2 Late® (iN2L) is the leading provider of person-centered digital engagement to the senior living market.

Cision View original content with multimedia:

SOURCE It’s Never 2 Late

Copyright 2014 PR Newswire. All Rights Reserved

Page: 1

Related Keywords:Adults,Family,
Related Sites: DMN Newswire , ,   HTN - Health Technology Net
Related Newsletter: DMNForums ,   Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter

  • Healthcare IT Market 2018 - 2023 with SWOT Analysis regarding upcoming Changes and Technology Adaptations in Global Healthcare Sector
  • Sciatica Market Research Valued 18.9 Billion US$ by 2023: A Comprehensive Sciatica Market Growth by by type, by Drug Treatment and by End User
  • Medical Sensors Market to be Worth US$18.74 Billion by 2023, Says TMR
  • Vision Care Product Market To Witness Enhanced Growth Owing To Rising Occurrence Of Eye Disorders Till 2021 | Million Insights
  • Global Prosthetic Heart Valve Market Reaching at a CAGR of +12.70% by Geography, Deployment Model, Component, and Key players are Boston Scientific Cardiology, CryoLife, Inc., Abbott

  • CStone Pharmaceuticals Appoints Former Goldman Sachs Executive Richard Yeh as CFO
  • Immune Advisors Publishes Peer-Reviewed Study Demonstrating Efficacy of a Probiotic and Digestive Enzymes Supplement in Protecting Against Side Effects of Cancer Chemotherapy
  • CytRx Corporation Announces Expiration of Outstanding Warrants
  • HedgePath Pharmaceuticals Granted Exclusive Option to License UCONN's Patented Chemical Analogues of Itraconazole
  • Alligator Bioscience Submits Application to Start Clinical Phase I Study in Cancer Patients with ATOR-1015, a Unique CTLA-4 and OX40 Binding Antibody

    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines